Business
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\n Los Angeles, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today it will hold a question and answer session for shareholders on March 9, 2023 at 4:30pm EST with Ira Weisberg, President of Endonovo’s Medical Division. The meeting and dialogue with shareholders will be virtual and accessible through the following ZOOM link: https://us02web.zoom.us/j/86916857785?pwd=VG5RRjlDSjJ0eTg3TFRpejFuN1M2Zz09. Weisberg will present detailed current and future Company plans, including updates on new products and marketing initiatives, especially focused on its proprietary SofPulse® PEMF technology medical devices, that are opioid-free and FDA cleared to reduce post-surgical pain and edema. SofPulse® devices have shown significant clinical results and ongoing benefits in accelerating healing and recovery in a range of medical applications, including orthopedics, sports medicine, general surgery, plastic surgery, pain management and wound care. Many Questions Have Already Been Submitted Relating to: Specifics on the SofPulse® path for greater growth and innovation;How Weisberg’s 25 years of experienced leadership and contacts in the medical device field bear on the future expansion of SofPulse® PEMF technology;Update on how the market evaluation is being conducted by Ocean Tomo;Progress on the planned spin-off of SofPulse® technology from Endonovo into the newly- formed SofPulse Inc.;Future plans for SofPulse Health™, its telehealth initiative as well as international and veterans market expansions. In making the announcement, Weisberg said: \"I am honored to join Endonovo as President of the Medical Device Division. The Company's PEMF technology has the potential to revolutionize the medical industry, and I am excited to lead the charge in bringing this technology to more patients and healthcare providers. I look forward to virtually meeting our shareholders and answering their questions regarding our current expansion and how we plan to make SofPulse® technology more available to consumers in the future.\" Ongoing Business Expansion Expansion initiatives created through Weisberg’s ongoing ‘Go to Market” campaign include: New international contr...